About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Molecular Medical Imaging research group focuses its activity on deepening the molecular bases and developing new areas of research in molecular signaling pathways and the identification of new theranostic targets.
We promote the confluence of basic and clinical researchers, experts in imaging and molecular biology to provide:
In this context, the creation of a translational imaging unit constitutes a basic objective for the development of research aimed at the personalized treatment of patients.
The group is made up of medical specialists in molecular imaging, chemists and pharmacists specializing in tracer synthesis, and biomedical engineers and physicists specializing in image processing and tomography equipment. These are affiliated with different institutions, such as the Vall d'Hebron Research Institute (VHIR), the Vall d'Hebron University Hospital (HUVH) and the Institute of Diagnostic Imaging (IDI).
IP: Andreea Ciudin Mihai Collaborators: Oscar González López, Fiorella Ximena Palmas Candia, Marina Giralt Arnaiz, Marta Comas Martínez, Rosa Burgos Peláez, Irene Hernández Hernández, Enzamaría Fidilio Meli, Efráin Santiago Cordero Vázquez, Cristina Gamez Cenzano Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI20/01086 Duration: 01/01/2021 - 31/12/2024
IP: Jordi Bove Badell Collaborators: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Thais Cuadros Arasa, Antonio Palasi Franco, David Ramos Vicente Funding agency: Instituto de Salud Carlos III Funding: 165770 Reference: PI21/01358 Duration: 01/01/2022 - 31/12/2024
IP: Lucas Moreno Martín-Retortillo Collaborators: Cristina Gamez Cenzano, Aroa Soriano Fernández, Luis Riera Soler, Miguel Segura Ginard, Carlota Aguilera Ordoñez, Sergio Manresa Vera Funding agency: Instituto de Salud Carlos III Funding: 826760.77 Reference: ICI21/00076 Duration: 01/01/2022 - 31/12/2025
IP: José Raul Herance Camacho Collaborators: Martha Sahylí Ortega Pijeira, Cristina Gamez Cenzano Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 216102 Reference: PLEC2021-008034 Duration: 01/10/2021 - 30/09/2024
PMID: 33512955 Journal: CLINICAL NUCLEAR MEDICINE Year: 2021 Reference: Clin Nucl Med. 2021 Apr 1;46(4):326-328. doi: 10.1097/RLU.0000000000003526. Impact factor: 7.794 Publication type: Letter or abstract Authors: Monturiol-Duran, Jaime Alejando, Iglesias-Felip, Carmela, Villasboas-Rosciolesi, Diego, Castell-Conesa, Joan, Garcia-Burillo, Amparo et al. DOI: 10.1097/RLU.0000000000003526
PMID: 33495853 Journal: BASIC RESEARCH IN CARDIOLOGY Year: 2021 Reference: Basic Res Cardiol. 2021 Jan 25;116(1):4. doi: 10.1007/s00395-021-00842-2. Impact factor: 17.165 Publication type: Paper in international publication Authors: Garcia Del Blanco, Bruno, Otaegui, Imanol, Rodriguez-Palomares, Jose F, Bayes-Genis, Antoni, Sambola, Antonia, Lidon, Rosa M, Baneras, Jordi, Elizaga, Jaime, Padilla, Ferran, Barrabes, Jose A et al. DOI: 10.1007/s00395-021-00842-2
PMID: 33497314 Journal: RADIOLOGY Year: 2021 Reference: Radiology. 2021 Apr;299(1):109-119. doi: 10.1148/radiol.2021200928. Epub 2021 Jan 26. Impact factor: 11.105 Publication type: Paper in international publication Authors: Felip, Enriqueta, Villacampa, Guillermo, Raciti, Maria V, Landa, Jaid, Matos, Ignacio, Martin-Liberal, Juan, Ochoa-de-Olza, Maria, Hierro, Cinta, Mateo, Joaquin, Gonzalez, Macarena et al. DOI: 10.1148/radiol.2021200928
PMID: 33485832 Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular Year: 2021 Reference: Rev Esp Med Nucl Imagen Mol. 2021 May-Jun;40(3):149-154. doi: 10.1016/j.remn.2020.06.003. Epub 2021 Jan 21. Impact factor: 1.359 Publication type: Paper in national publication Authors: Bergesio, Fabrizio, De Maggi, Adriano, Coronado, Monica, Pardal, Emilia, Plaza, Rafael, Hernandez, Ana Cristina, Sarandeses, Maria Del Pilar, Cortes, Montserrat, Setoain, Xavier, Simo, Marc et al. DOI: 10.1016/j.remn.2020.06.003
The device, called Winco USG, is a simulation platform for holistic and integrated training of professionals performing this type of procedure.
Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.
The team will investigate, in animal models, the benefits of histotripsy, a technique that allows tumors to be destroyed without incision or heat, and hopes to minimize the risks and enhance the efficacy of immunotherapy.
